REGN vs TNC · P/E 14, rev $14.34B vs P/E 51, rev $1.29B
Regeneron Pharmaceuticals Inc (REGN) versus Tennant Company (TNC) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Tennant Company (TNC) is a specialty industrial machinery company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported TNC revenue for 2024-12-31 was $1.29B. Net income was $83.7M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. TNC currently screens at market cap $1.46B and trailing P/E 51.1.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TNC currently screens at market cap $1.46B and trailing P/E 51.1.
Not investment advice. Open the REGN and TNC stock pages for the full models.
Not investment advice.